Mutations in the C, D, and V open reading frames of human parainfluenza virus type 3 attenuate replication in rodents and primates

Virology

Volumn 261, Issue 2, 1999, Pages 319-330

  Durbin, Anna P ^a   McAuliffe, Josephine M ^a   Collins, Peter L ^a   Murphy, Brian R ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIVE VACCINE; MESSENGER RNA; METHIONINE; RECOMBINANT VACCINE; THREONINE; VIRUS PROTEIN;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; GENE MUTATION; HEP 2 CELL; HUMAN; HUMAN CELL; LOWER RESPIRATORY TRACT; NONHUMAN; OPEN READING FRAME; PARAINFLUENZA VIRUS 3; POINT MUTATION; PRIMATE; PRIORITY JOURNAL; RECOMBINANT DNA TECHNOLOGY; RNA EDITING; RNA TRANSCRIPTION; RODENT; SYRIAN HAMSTER; TEMPERATURE SENSITIVE MUTANT; UPPER RESPIRATORY TRACT; VIRUS ATTENUATION; VIRUS GENE; VIRUS MUTANT; VIRUS REPLICATION; VIRUS VIRULENCE;

ANIMALIA; CRICETINAE; DNA VIRUSES; HUMAN PARAINFLUENZA VIRUS 3; MESOCRICETUS AURATUS; MONONEGAVIRALES; PARAMYXOVIRIDAE; PRIMATES; RESPIROVIRUS; RNA VIRUSES; RODENTIA; SENDAI VIRUS;

EID: 0033198543     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1999.9878     Document Type: Article

References (53)

1. Baron M. D., Barrett T. Rescue of rinderpest virus from cloned cDNA. J. Virol. 71:1997;1265-1271.
2. Bellini W. J., Englund G., Rozenblatt S., Arnheiter H., Richardson C. D. Measles virus P gene codes for two proteins. J. Virol. 53:1985;908-919.
3. Cadd T., Garcin D., Tapparel C., Itoh M., Homma M., Roux L., Curran J., Kolakofsky D. The Sendai paramyxovirus accessory C proteins inhibit viral genome amplification in a promoter-specific fashion. J. Virol. 70:1996;5067-5074.
4. Cattaneo R., Kaelin K., Baczko K., Billeter M. A. Measles virus editing provides an additional cysteine-rich protein. Cell. 56:1989;759-764.
5. Collins P. L., Chanock R. M., McIntosh K. Parainfluenza viruses. Fields B. N., Knipe D. M., Howley P. M., Chanock R. M., Melnick J. L., Monath T. P., Roizman B., Straus S. E. Fields Virology. 1996;1205-1243 Lippincott-Raven Publishers, Philadelphia.
6. Collins P. L., Hill M. G., Camargo E., Grosfeld H., Chanock R. M., Murphy B. R. Production of infectious human respiratory syncytial virus from cloned cDNA confirms an essential role for the transcription elongation factor from the 5′ proximal open reading frame of the M2 mRNA in gene expression and provides a capability for vaccine development. Proc. Natl. Acad. Sci. USA. 92:1995;11563-11567.
7. Crowe J. E. Jr. Current approaches to the development of vaccines against disease caused by respiratory syncytial virus (RSV) and parainfluenza virus (PIV): A meeting report of the WHO Programme for Vaccine Development. Vaccine. 13:1995;415-421.
8. Curran J., Boeck R., Kolakofsky D. The Sendai virus P gene expresses both an essential protein and an inhibitor of RNA synthesis by shuffling modules via mRNA editing. EMBO J. 10:1991;3079-3085.
9. Curran J., Kolakofsky D. Sendai virus P gene produces multiple proteins from overlapping open reading frames. Enzyme. 44:1990;244-249.
10. Curran J., Marq J. B., Kolakofsky D. The Sendai virus nonstructural C proteins specifically inhibit viral mRNA synthesis. Virology. 189:1992;647-656.
11. Delenda C., Hausmann S., Garcin D., Kolakofsky D. Normal cellular replication of Sendai virus without the trans-frame, nonstructural V protein. Virology. 228:1997;55-62.
12. Delenda C., Taylor G., Hausmann S., Garcin D., Kolakofsky D. Sendai viruses with altered P, V, and W protein expression. Virology. 242:1998;327-337.
13. Durbin A. P., Hall S. L., Siew J. W., Whitehead S. S., Collins P. L., Murphy B. R. Recovery of infectious human parainfluenza virus type 3 from cDNA. Virology. 235:1997a;323-332.
14. Durbin A. P., Siew J. W., Murphy B. R., Collins P. L. Minimum protein requirements for transcription and RNA replication of a minigenome of human parainfluenza virus type 3 and evaluation of the rule of six. Virology. 234:1997b;74-83.
15. Durbin A. P., Wyatt L. S., Siew J., Moss B., Murphy B. R. The immunogenicity and efficacy of intranasally or parenterally administered replication-deficient vaccinia-parainfluenza virus type 3 recombinants in rhesus monkeys. Vaccine. 16:1998;1324-1330.
16. Escoffier C., Manie S., Vincent S., Muller C. P., Billeter M., Gerlier D. Nonstructural C protein is required for efficient measles virus replication in human peripheral blood cells. J. Virol. 73:1999;1695-1698.
17. Galinski M. S., Troy R. M., Banerjee A. K. RNA editing in the phosphoprotein gene of the human parainfluenza virus type 3. Virology. 186:1992;543-550.
18. Garcin D., Itoh M., Kolakofsky D. A point mutation in the Sendai virus accessory C proteins attenuates virulence for mice, but not virus growth in cell culture. Virology. 238:1997;424-431.
19. Garcin D., Pelet T., Calain P., Roux L., Curran J., Kolakofsky D. A highly recombinogenic system for the recovery of infectious Sendai paramyxovirus from cDNA: Generation of a novel copy-back nondefective interfering virus. EMBO J. 14:1995;6087-6094.
20. Hall S. L., Stokes A., Tierney E. L., London W. T., Belshe R. B., Newman F. C., Murphy B. R. Cold-passaged human parainfluenza type 3 viruses contain ts and non-ts mutations leading to attenuation in rhesus monkeys. Virus Res. 22:1992;173-184.
21. He B., Paterson R. G., Ward C. D., Lamb R. A. Recovery of infectious SV5 from cloned DNA and expression of a foreign gene. Virology. 237:1997;249-260.
22. Heikkinen T., Thint M., Chonmaitree T. Prevalence of various respiratory viruses in the middle ear during acute otitis media. N. Engl. J. Med. 340:1999;260-264.
23. Hoffman M. A., Banerjee A. K. An infectious clone of human parainfluenza virus type 3. J. Virol. 71:1997;4272-4277.
24. Itoh M., Isegawa Y., Hotta H., Homma M. Isolation of an avirulent mutant of Sendai virus with two amino acid mutations from a highly virulent field strain through adaptation to LLC-MK2 cells. J. Gen. Virol. 78:1997;3207-3215.
25. Karron R. A., Makhene M., Gay K., Wilson M. H., Clements M. L., Murphy B. R. Evaluation of a live attenuated bovine parainfluenza type 3 vaccine in two- to six-month-old infants. Pediatr. Infect. Dis. J. 15:1996;650-654.
26. Karron R. A., Wright P. F., Hall S. L., Makhene M., Thompson J., Burns B. A., Tollefson S., Steinhoff M. C., Wilson M. H., Harris D. O., Clements M. L., Murphy B. R. A live attenuated bovine parainfluenza virus type 3 vaccine is safe, infectious, immunogenic, and phenotypically stable in infants and children. J. Infect. Dis. 171:1995a;1107-1114.
27. Karron R. A., Wright P. F., Newman F. K., Makhene M., Thompson J., Samorodin R., Wilson M. H., Anderson E. L., Clements M. L., Murphy B. R., Belshe R. B. A live human parainfluenza type 3 virus vaccine is attenuated and immunogenic in healthy infants and children. J. Infect. Dis. 172:1995b;1445-1450.
28. Kato A., Kiyotani K., Sakai Y., Yoshida T., Nagai Y. The paramyxovirus, Sendai virus, V protein encodes a luxury function required for viral pathogenesis. EMBO J. 16:1997a;578-587.
29. Kato A., Kiyotani K., Sakai Y., Yoshida T., Shioda T., Nagai Y. Importance of the cysteine-rich carboxyl-terminal half of V protein for Sendai virus pathogenesis. J. Virol. 71:1997b;7266-7272.
30. Kato A., Sakai Y., Shioda T., Kondo T., Nakanishi M., Nagai Y. Initiation of Sendai virus multiplication from transfected cDNA or RNA with negative or positive sense. Genes Cells. 1:1996;569-579.
31. Kunkel T. A., Roberts J. D., Zakour R. A. Rapid and efficient site-specific mutagenesis without phenotypic selection. Methods Enzymol. 154:1987;367-382.
32. Kurotani A., Kiyotani K., Kato A., Shioda T., Sakai Y., Mizumoto K., Yoshida T., Nagai Y. Sendai virus C proteins are categorically nonessential gene products but silencing their expression severely impairs viral replication and pathogenesis. Genes Cells. 3:1998;111-124.
33. Lamb R. A., Paterson R. G. The nonstructural proteins of paramyxoviruses. Kingsbury D. The Paramyxoviruses. 1991;181-214 Plenum Press, New York.
34. Latorre P., Cadd T., Itoh M., Curran J., Kolakofsky D. The various Sendai virus C proteins are not functionally equivalent and exert both positive and negative effects on viral RNA accumulation during the course of infection. J. Virol. 72:1998;5984-5993.
35. Liston P., Briedis D. J. Ribosomal frameshifting during translation of measles virus P protein mRNA is capable of directing synthesis of a unique protein. J. Virol. 69:1995;6742-6750.
36. Marx A., Torok T. J., Holman R. C., Clarke M. J., Anderson L. J. Pediatric hospitalizations for croup (laryngotracheobronchitis): biennial increases associated with human parainfluenza virus 1 epidemics. J. Infect. Dis. 176:1997;1423-1427.
37. Matsuoka Y., Curran J., Pelet T., Kolakofsky D., Ray R., Compans R. W. The P gene of human parainfluenza virus type 1 encodes P and C proteins but not a cysteine-rich V protein. J. Virol. 65:1991;3406-3410.
38. Park K. H., Krystal M. In vivo model for pseudo-templated transcription in Sendai virus. J. Virol. 66:1992;7033-70399.
39. Pelet T., Curran J., Kolakofsky D. The P gene of bovine parainfluenza virus 3 expresses all three reading frames from a single mRNA editing site. EMBO J. 10:1991;443-448.
40. Radecke F., Billeter M. A. The nonstructural C protein is not essential for multiplication of Edmonston B strain measles virus in cultured cells. Virology. 217:1996;418-421.
41. Radecke F., Spielhofer P., Schneider H., Kaelin K., Huber M., Dotsch C., Christiansen G., Billeter M. A. Rescue of measles viruses from cloned DNA. EMBO J. 14:1995;5773-5784.
42. Sanchez A., Banerjee A. K. Cloning and gene assignment of mRNAs of human parainfluenza virus 3. Virology. 147:1985;177-186.
43. Schnell M. J., Mebatsion T., Conzelmann K. K. Infectious rabies viruses from cloned cDNA. EMBO J. 13:1994;4195-4203.
44. Skiadopoulos M. H., Surman S., Tatem J. M., Paschalis M., Wu S. L., Udem S. A., Durbin A. P., Collins P. L., Murphy B. R. Identification of mutations contributing to the temperature-sensitive, cold-adapted, and attenuation phenotypes of the live-attenuated cold- passage 45 (cp45) human parainfluenza virus 3 candidate vaccine. J. Virol. 73:1999;1374-1381.
45. Spriggs M. K., Collins P. L. Sequence analysis of the P and C protein genes of human parainfluenza virus type 3: Patterns of amino acid sequence homology among paramyxovirus proteins. J. Gen. Virol. 67:1986;2705-2719.
46. Takeda M., Kato A., Kobune F., Sakata H., Li Y., Shioda T., Sakai Y., Asakawa M., Nagai Y. Measles virus attenuation associated with transcriptional impediment and a few amino acid changes in the polymerase and accessory proteins. J. Virol. 72:1998;8690-8696.
47. Thomas S. M., Lamb R. A., Paterson R. G. Two mRNAs that differ by two nontemplated nucleotides encode the amino coterminal proteins P and V of the paramyxovirus SV5. Cell. 54:1988;891-902.
48. Valsamakis A., Schneider H., Auwaerter P. G., Kaneshima H., Billeter M. A., Griffin D. E. Recombinant measles viruses with mutations in the C, V, or F gene have altered growth phenotypes in vivo. J. Virol. 72:1998;7754-7761.
49. van Wyke Coelingh K. L., Winter C., Murphy B. R. Antigenic variation in the hemagglutinin-neuraminidase protein of human parainfluenza type 3 virus. Virology. 143:1985;569-582.
50. van Wyke Coelingh K. L., Winter C. C., Jorgensen E. D., Murphy B. R. Antigenic and structural properties of the hemagglutinin-neuraminidase glycoprotein of human parainfluenza virus type 3: sequence analysis of variants selected with monoclonal antibodies which inhibit infectivity, hemagglutination, and neuraminidase activities. J. Virol. 61:1987;1473-1477.
51. Vidal S., Curran J., Kolakofsky D. Editing of the Sendai virus P/C mRNA by G insertion occurs during mRNA synthesis via a virus-encoded activity. J. Virol. 64:1990;239-246.
52. Whelan S. P., Ball L. A., Barr J. N., Wertz G. T. Efficient recovery of infectious vesicular stomatitis virus entirely from cDNA clones. Proc. Natl. Acad. Sci. USA. 92:1995;8388-8392.
53. Wyatt L. S., Moss B., Rozenblatt S. Replication-deficient vaccinia virus encoding bacteriophage T7 RNA polymerase for transient gene expression in mammalian cells. Virology. 210:1995;202-205.